Why dozens of Chinese firms are joining the weight loss drugs fray
South China Morning Post - TechThursday, July 10, 2025 at 6:00:14 AM
Dozens of Chinese pharmaceutical companies are jumping into the booming weight-loss drug market, racing to develop their own versions of the highly effective medications that have taken the West by storm. With over 60 late-stage clinical trials underway, these homegrown treatments could soon challenge big-name players like Novo Nordisk and Eli Lilly. The surge is fueled by global demand, rising obesity rates, and the viral hype around these drugs—but whether China’s contenders can compete on quality and scale remains to be seen.
Editor’s Note: This isn’t just about another industry trend—it’s a sign of how quickly China’s pharma sector is maturing. If these drugs succeed, they could shake up a market dominated by Western firms and make weight-loss treatments more accessible worldwide. But it also raises questions about safety, affordability, and whether this gold rush will lead to real innovation or just copycat solutions. Either way, it’s a space worth watching.
— Curated via WP Now’s
